44904-1 |
Malignant cells/Cells |
NFr |
Pericard fld |
Pt |
Qn |
|
|
ACTIVE |
Malignant cells/cells in Pericardial fluid |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
44904-1 |
|
|
|
|
Both |
|
|
|
0 |
Malignant cells NFr Pcar |
|
|
|
N |
|
Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Malig; Number fraction; Pcar; Percent; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.79 |
2.17 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
44905-8 |
Malignant cells/Cells |
NFr |
Periton fld |
Pt |
Qn |
|
|
ACTIVE |
Malignant cells/cells in Peritoneal fluid |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
44905-8 |
|
|
|
|
Both |
|
|
|
0 |
Malignant cells NFr Prt |
|
|
|
N |
|
Ascites; Ascitic fluid; Ascitis; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Malig; Number fraction; Percent; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random |
2.79 |
2.17 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
44906-6 |
Homovanillate panel |
- |
Urine |
24H |
- |
|
|
ACTIVE |
Homovanillate panel - 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
44906-6 |
|
|
|
|
Order |
|
|
|
0 |
Homovanillate Pnl 24h Ur |
|
|
|
N |
|
1 day; 24 hours; 24HR; 3-methoxy-4-hydroxy-phenylacetic acid; Chemistry; Homovanilic; Homovanillate Pnl; Homovanillic acid; HVA; Pan; PANEL.CHEMISTRY; Panl; Pnl; Tumor marker; UA; UR; Urn |
2.73 |
2.17 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
44907-4 |
5-Hydroxyindoleacetate panel |
- |
Urine |
24H |
- |
|
|
ACTIVE |
5-Hydroxyindoleacetate panel - 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
44907-4 |
|
|
|
|
Order |
|
|
|
0 |
5HIAA Pnl 24h Ur |
|
|
|
N |
|
1 day; 24 hours; 24HR; 5HIA; 5HIAA; 5-HIAA; 5HIAA Pnl; 5-Hydroxy indoleacetate; 5-hydroxyindoleacetic acid; 5OH-indoleacetate; Chemistry; Hydroxyindoacet; Oncology; Pan; PANEL.CHEMISTRY; Panl; Pnl; Serotonin metabolite; Tumor marker; UA; UniversalLabOrders; UR; Urn |
2.73 |
2.17 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
44908-2 |
Homovanillate & Creatinine |
Imp |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Homovanillate and Creatinine [Interpretation] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44908-2 |
|
|
|
|
Observation |
|
|
|
0 |
HVA & Creat Ur-Imp |
|
|
|
N |
|
3-methoxy-4-hydroxy-phenylacetic acid; Chemistry; CR; Crea; Creat; Homovanilic; Homovanillic acid; HVA; HVA & Creat; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Tumor marker; UA; UCr; UR; Urn |
2.38 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44909-0 |
5-Hydroxyindoleacetate & Creatinine |
Imp |
Urine |
Pt |
Nom |
|
|
ACTIVE |
5-Hydroxyindoleacetate and Creatinine [Interpretation] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44909-0 |
|
|
|
|
Observation |
|
|
|
0 |
5HIAA & Creatinine Ur-Imp |
|
|
|
N |
|
5HIA; 5HIAA; 5-HIAA; 5HIAA & Creatinine; 5-Hydroxy indoleacetate; 5-hydroxyindoleacetic acid; 5OH-indoleacetate; Chemistry; CR; Crea; Creat; Hydroxyindoacet; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Oncology; Point in time; Random; Serotonin metabolite; Tumor marker; UA; UCr; UR; Urn |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
4491-7 |
Complement C3c |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Complement C3c [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
HEM/BC |
|
4491-7 |
|
|
|
|
Both |
|
|
|
0 |
C3c SerPl-mCnc |
|
|
|
Y |
|
Comp; Complmt; HEMATOLOGY/CELL COUNTS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
44910-8 |
Alpha-1-Fetoprotein |
ACnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Alpha-1-Fetoprotein [Units/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
IU/mL |
|
|
|
|
|
|
CHEM |
|
44910-8 |
|
|
|
|
Both |
|
|
|
0 |
AFP Fld-aCnc |
|
|
|
N |
|
A1; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Arbitrary concentration; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Feto; Fl; Fld; FLU; Fluid; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker |
2.7 |
2.17 |
|
|
|
|
|
|
|
[IU]/mL |
|
|
|
0 |
44911-6 |
Beta 2 globulin+Gamma globulin |
MCnc |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Beta 2 globulin+Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
44911-6 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Beta2+Gamma Glob SerPl Elph-mCnc |
|
|
|
N |
|
B; B2 globulin; Beta2 Glob; Beta2+Gamma Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.17 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
44912-4 |
Beta 2 globulin+Gamma globulin/Protein.total |
MFr |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Beta 2 globulin+Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
44912-4 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Beta2+Gamma Glob MFr SerPl Elph |
|
|
|
N |
|
B; B2 globulin; Beta2 Glob; Beta2+Gamma Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP |
2.7 |
2.17 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
44913-2 |
Beta globulin+Gamma globulin |
MCnc |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Beta globulin+Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
44913-2 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
B+G-Globulin SerPl Elph-mCnc |
|
|
|
N |
|
B; B+G-Globulin; B-Globulin; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein beta globulin; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.17 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
44914-0 |
Beta globulin+Gamma globulin/Protein.total |
MFr |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Beta globulin+Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
44914-0 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
B+G-Globulin MFr SerPl Elph |
|
|
|
N |
|
B; B+G-Globulin; B-Globulin; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; Protein beta globulin; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP |
2.7 |
2.17 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
44915-7 |
Cholesterol.in LDL/Cholesterol.in HDL |
SRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cholesterol in LDL/Cholesterol in HDL [Molar ratio] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
44915-7 |
|
|
|
|
Observation |
|
|
|
0 |
LDLc/HDLc SerPl-sRto |
|
|
|
N |
|
Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; LDLc; LDL-C; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; TCHHDL |
2.73 |
2.17 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44916-5 |
Cortisol^pre XXX challenge |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --pre XXX challenge |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
44916-5 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis pre chal SerPl-sCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.17 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
44917-3 |
Cortisol^post dose dexamethasone |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --post dose dexamethasone |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
44917-3 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis p Dex SerPl-sCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; F; Hexadrol; hydrocortisone; Level; p Dex; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.17 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
44918-1 |
DOPamine/Creatinine |
SRto |
Urine |
24H |
Qn |
|
|
ACTIVE |
DOPamine/Creatinine [Molar ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mol;nmol/mmol creat |
|
|
|
|
|
|
CHEM |
|
44918-1 |
|
|
|
|
Both |
|
|
|
0 |
DOPamine/Creat 24h Ur-sRto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.17 |
|
|
|
|
|
|
|
umol/mol{creat} |
|
|
|
0 |
44919-9 |
Glucose^1.5H post meal |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --1.5 hours post meal |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
44919-9 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 1.5h p meal SerPl-sCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p meal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
2.17 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
4492-5 |
Complement C3d |
EntNum |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Complement C3d [Entitic number] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
4492-5 |
|
|
|
|
Both |
|
|
|
0 |
C3d EntNum RBC |
|
|
|
|
|
Comp; Complmt; Entitic; Entitic number; Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles |
2.26 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
44920-7 |
Hemoglobin C/Hemoglobin.total |
MFr |
Bld |
Pt |
Qn |
HPLC |
|
ACTIVE |
Hemoglobin C/Hemoglobin.total in Blood by HPLC |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
44920-7 |
|
HPLC |
|
|
Observation |
|
|
|
0 |
Hgb C MFr Bld HPLC |
|
|
|
N |
|
Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb C; High performance liquid chromatography; High pressure liquid chromatography; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood |
2.73 |
2.17 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
44921-5 |
Hemoglobin D/Hemoglobin.total |
MFr |
Bld |
Pt |
Qn |
HPLC |
|
ACTIVE |
Hemoglobin D/Hemoglobin.total in Blood by HPLC |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
44921-5 |
|
HPLC |
|
|
Observation |
|
|
|
0 |
Hgb D MFr Bld HPLC |
|
|
|
N |
|
Blood; Dextro; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb D; High performance liquid chromatography; High pressure liquid chromatography; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood |
2.73 |
2.17 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
44922-3 |
Hemoglobin E/Hemoglobin.total |
MFr |
Bld |
Pt |
Qn |
HPLC |
|
ACTIVE |
Hemoglobin E/Hemoglobin.total in Blood by HPLC |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
44922-3 |
|
HPLC |
|
|
Both |
|
|
|
0 |
Hgb E MFr Bld HPLC |
|
|
|
N |
|
Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb E; High performance liquid chromatography; High pressure liquid chromatography; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood |
2.73 |
2.17 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
44923-1 |
Hemoglobin S/Hemoglobin.total |
MFr |
Bld |
Pt |
Qn |
HPLC |
|
ACTIVE |
Hemoglobin S/Hemoglobin.total in Blood by HPLC |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
44923-1 |
|
HPLC |
|
|
Both |
|
|
|
0 |
Hgb S MFr Bld HPLC |
|
|
|
N |
|
Blood; Haemoglobin; Hb; HBs; HEMATOLOGY/CELL COUNTS; Hgb; Hgb S; High performance liquid chromatography; High pressure liquid chromatography; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Sickle cell; Sickle cells; Tot; Totl; WB; Whole blood |
2.73 |
2.17 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
44924-9 |
Normetanephrine/Creatinine |
SRto |
Urine |
24H |
Qn |
|
|
ACTIVE |
Normetanephrine/Creatinine [Molar ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
44924-9 |
|
|
|
|
Observation |
|
|
|
0 |
Normetanephrine/Creat 24h Ur-sRto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Normeta; Normetaneph; Normetanephrn; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.73 |
2.17 |
|
|
|
|
|
|
|
nmol/mmol{creat} |
|
|
|
0 |
44925-6 |
Prolactin^1H post dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prolactin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
44925-6 |
|
|
|
|
Observation |
|
|
|
0 |
Prolactin 1h p TRH IV SerPl-aCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p TRH; 1h p TRH IV; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.17 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
44926-4 |
Prolactin^1.5H post dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prolactin [Units/volume] in Serum or Plasma --1.5 hours post dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L |
|
|
|
|
|
|
CHAL |
|
44926-4 |
|
|
|
|
Observation |
|
|
|
0 |
Prolactin 1.5h p TRH IV SerPl-aCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p TRH; 1.5h p TRH IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammotropin; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.17 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |